Edition:
United States

Allergan plc (AGN.N)

AGN.N on New York Stock Exchange

204.65USD
22 Sep 2017
Change (% chg)

$1.99 (+0.98%)
Prev Close
$202.66
Open
$202.50
Day's High
$209.24
Day's Low
$201.51
Volume
710,828
Avg. Vol
512,986
52-wk High
$256.78
52-wk Low
$184.58

Select another date:

Fri, Sep 22 2017

BRIEF-Allergan receives refusal to file letter from FDA for Vraylar SNDA

* Allergan receives refusal to file letter from FDA for Vraylar (Cariprazine) supplemental new drug application (SNDA) for the treatment of negative symptoms in Schizophrenia

Native American tribe moves to dismiss Allergan patent case

A Native American tribe holding patents for drugmaker Allergan Plc on Friday moved to dismiss a case brought by generic drug company Mylan NV challenging the patents.

Native American tribe moves to dismiss Allergan patent case

A Native American tribe holding patents for drugmaker Allergan Plc on Friday moved to dismiss a case brought by generic drug company Mylan NV challenging the patents.

UPDATE 1-Native American tribe moves to dismiss Allergan patent case

Sept 22 A Native American tribe holding patents for drugmaker Allergan Plc on Friday moved to dismiss a case brought by generic drug company Mylan NV challenging the patents.

Native American tribe moves to dismiss Allergan patent case

Sept 22 A Native American tribe holding patents for drugmaker Allergan Plc on Friday moved to dismiss a case brought by generic drug company Mylan NV challenging the patents.

BRIEF-Allergan Plc says new data from phase 2b study supports continued development of cenicriviroc in ongoing phase 3 trial

* New data from CENTAUR phase 2b clinical study supports continued development of cenicriviroc (CVC) in ongoing phase 3 AURORA trial

U.S. senator slams Allergan patent deal with Native-American tribe

U.S. Senator Sherrod Brown said on Friday a deal that drugmaker Allergan Plc made with a Native-American tribe to shield patents "rips off consumers" and cannot "become the new normal."

U.S. senator slams Allergan patent deal with Native-American tribe

U.S. Senator Sherrod Brown said on Friday a deal that drugmaker Allergan Plc made with a Native-American tribe to shield patents "rips off consumers" and cannot "become the new normal."

UPDATE 2-U.S. senator slams Allergan patent deal with Native-American tribe

Sept 15 U.S. Senator Sherrod Brown said on Friday a deal that drugmaker Allergan Plc made with a Native-American tribe to shield patents "rips off consumers" and cannot "become the new normal."

U.S. senator slams Allergan tribal patent deal

Sept 15 U.S. Senator Sherrod Brown said on Friday a deal Allergan Plc made with a Native American tribe to shield its patents "rips off consumers" and cannot "become the new normal."

Select another date: